(Q37247571)

19 August 2017

1 reference

title

The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics (English)

1 reference

19 August 2017

1 reference

L J Lesko

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Clinical Pharmacology & Therapeutics

19 August 2017

published in

1 reference

19 August 2017

volume

84

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

301-303

1 reference

Medication use leading to emergency department visits for adverse drug events in older adults

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Managing oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Major bleeding complications in a specialized anticoagulation service

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Genetic determinants of response to warfarin during initial anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Equal proportion of adult male and female homozygous for the 677C ? T mutation in the methylenetetrahydrofolate reductase polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.133

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2008.133

1 reference

Dimensions Publication ID

19 August 2017

1047916112

0 references

1 reference